Next 10 |
2024-03-28 13:42:43 ET More on Aldeyra Therapeutics Aldeyra: Derisked Biotech Eyeing Path To Approval And Finalizing Deal With AbbVie Why Aldeyra Therapeutics Is A Strong Buy: AbbVie Agreement And Reproxalap's Prospects Seeking Alpha’s Quant Rating on Aldeyra ...
2024-03-27 10:45:02 ET AES Corp. (AES) AES is trading UP for the last 5 days, and it at trading at $16.90 with volume of 1,733,178 and a one day change of $0.26 (1.56%). AES Corp. has a 52-week low of 11.43 and a 52-week high of $25.74. The business's 50-day moving average price is ...
2024-03-27 02:09:28 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2024-03-25 12:17:33 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Landos Biopharma (NASDAQ: LABP ) stock is on the rise Monday after the company announced an acquisition deal with AbbVie (NYSE: ABBV ). AbbVie is acquiring ...
2024-03-25 11:05:30 ET More on Landos Biopharma Seeking Alpha’s Quant Rating on Landos Biopharma Historical earnings data for Landos Biopharma Financial information for Landos Biopharma Read the full article on Seeking Alpha For further details...
Allergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in Aesthetics PR Newswire Allergan Aesthetics is raising the conversation on patient safety and ethical standards As part of its established Aesthetics-Ethics program...
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases PR Newswire Landos' lead asset, NX-13, is a first-in-class, oral NLRX1 agonist in Phase 2 for the treatment of ulcerative colitis (UC) NORTH CHICAGO, Ill...
2024-03-24 00:46:24 ET Summary Lead asset, reproxalap, has clear path to regulatory approval in Dry Eye Disease. Option deal for commercial license with AbbVie signed - $400M in milestones, 60/40 profit shares of US market and tiered double-digit royalties for ex-US. $142M in ...
2024-03-22 18:01:23 ET More on AbbVie AbbVie Inc. (ABBV) Barclays 26th Annual Global Healthcare Conference (Transcript) AbbVie: Comeback Expected After Humira Patent Expiration AbbVie Stock: I Was So Wrong, But This Is Way Too Fast AbbVie CEO marks final year...
U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients PR Newswire - The full approval of ELAHERE is based on the confirmatory MIRASOL Phase 3 trial that supports the medicine as a p...
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 10:45:02 ET AES Corp. (AES) AES is trading UP for the last 5 days, and it at trading at $16.90 with volume of 1,733,178 and a one day change of $0.26 (1.56%). AES Corp. has a 52-week low of 11.43 and a 52-week high of $25.74. The business's 50-day moving average price is ...
In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry obse...
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 whil...